Comorbidities impact a large proportion of patients with chronic obstructive pulmonary
disease (COPD), with over 80% of patients with COPD estimated to have at least one …

Chronic obstructive pulmonary disease (COPD) is a major incurable global health burden
and is currently the 4th largest cause of death in the world. Importantly, much of the disease …

Context The frequency of remission of type 2 diabetes achievable with lifestyle intervention
is unclear. Objective To examine the association of a long-term intensive weight-loss …

In this article, we focus on the scientific evidence from randomised trials supporting
treatment with inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease …

The objective of this systematic review was to discuss our current understanding of the
complex relationship between chronic obstructive pulmonary disease (COPD) and type-2 …

Abstract The Finnish Medical Society Duodecim initiated and managed the update of the
Finnish national guideline for chronic obstructive pulmonary disease (COPD). The Finnish …

Asthma is a heterogeneous disease with many phenotypes, and age at disease onset is an
important factor in separating the phenotypes. Most studies with asthma have been …

Diabetes mellitus is a chronic, progressive, incompletely understood metabolic disorder
whose prevalence has been increasing steadily worldwide. Even though little attention has …

Background Chronic obstructive pulmonary disease (COPD) is associated with multiple
comorbidities, which impact negatively on patients and are often underdiagnosed, thus …

Chronic obstructive pulmonary disease, metabolic syndrome and diabetes mellitus are
common and underdiagnosed medical conditions. It was predicted that chronic obstructive …